$AZZ

AZZ Raises Fiscal 2027 Outlook After Revenue Climbs 16.7%

AZZ Inc. (AZZ) raised its fiscal 2027 outlook after reporting Q2 revenue of $486.9M, up 16.7% YoY, and adjusted earnings of $2.00 per share, exceeding estimates. Net income fell to $58.5M due to a prior-year asset sale gain. The company increased revenue and earnings forecasts, citing organic growth and acquisitions. Shares gained 2.2% in extended trading.

Original reporting
Published Oct 13, 2026, 9:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 5:52 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AZZ Raises Fiscal 2027 Outlook After Revenue Climbs 16.7% — source image
Decision brief

The 30-second read

$AZZBullishMed
01

Why it matters

The earnings beat and guidance lift are likely to attract buying interest, especially after the 2.2% post‑market rally.

02

Market read

First‑report earnings and guidance update for AZZ, a small‑cap industrial coatings company, with immediate price impact.

03

What to watch

Higher input costs or slower demand from HVAC and transportation customers could pressure margins.

Relevance 7/10Novelty 8/10Timing: extended trading today

Background

AZZ Inc. reported Q2 2026 results, beating revenue and EPS estimates, and raised its FY2027 outlook.

Company-level read

Ticker impact

$AZZBullishHigh confidence
Context

AZZ raised FY2027 revenue and earnings guidance after a strong Q2 beat, sending the stock up 2.2% in extended trading.

Expected impact

upward pressure as investors price in higher revenue and earnings outlook

Evidence & confidence

The company beat Q2 estimates, raised revenue guidance to $1.825‑$1.875B and EPS guidance to $7.00‑$7.30, and announced a $20M buyback, all fresh data.

Market effects

Improves outlook for the metal coatings and specialty chemicals sector, potentially lifting peers.

Positive for U.S. industrial manufacturers and suppliers in the Midwest region.

Modest, limited to specialty coatings niche.

Counterpoint

If the guidance increase is already priced in, the stock may face a short‑term pullback.

Key entities

  • Tom Ferguson

    President and CEO of AZZ, commented on organic growth and acquisitions.

Related articles

$AZZHighAI 8/10

AZZ Inc (AZZ) (Q2 2027) Earnings Call Highlights: Record Sales, Raised Guidance, and a 29% EPS Jump

AZZ Inc reported Q2 2027 earnings with record sales, raised guidance, and a 29% EPS jump. The company cited strong demand in Metal Coatings and the Seattle Galvanizing acquisition's performance. Challenges include softer HVAC volume, tight steel substrate markets, and potential margin pressure from tariffs. The debt reduction target was lowered to $100-$140 million due to the acquisition.

$AZZMedAI 8/10

What AZZ (AZZ) Said on Its Q2 Earnings Call

AZZ Inc. reported Q2 earnings, highlighting the acquisition of Seattle Galvanizing and organic expansions. Sales grew in construction, industrial, and transportation sectors. The company raised its fiscal 2027 outlook, expecting sales of $1.825B-$1.875B and adjusted EBITDA of $380M-$420M. AZZ also updated its debt reduction target due to the acquisition.

$AZZHighAI 8/10

AZZ (AZZ) Q2 2027 Earnings Call Transcript

AZZ reported Q2 2027 earnings with record sales of $486.9M, up 16.7% YoY. Metal Coatings sales rose 22.9%, while Precoat Metals sales increased 11.5%. Adjusted EPS grew 29% to $2.00. The company completed the Seattle Galvanizing acquisition and is expanding capacity in key markets. Operating cash flow was $102.8M, with adjusted EBITDA at $110.9M. The Washington, Missouri facility is ramping up as planned, contributing to profitability.

$AZZMed

Barclays initiates AZZ stock with Equalweight rating on valuation

Barclays initiated coverage on AZZ Inc. (NYSE:AZZ) with an Equalweight rating and $140 price target, citing its market position and growth prospects. The stock trades at $136.71, below both the target and InvestingPro’s Fair Value of $139.07. Barclays noted AZZ’s pricing power, market share gains, and accretive greenfield plant, but believes positives are reflected in the share price.

$AZZMed

AZZ Q2 FY2027 Net Income Falls to $58.5M as Sales Rise 16.7% – Minichart

AZZ Inc. (NYSE: AZZ) reported Q2 FY2027 net income of $58.5M, down from $89.3M YoY, despite a 16.7% revenue increase to $486.9M. Gross margin rose slightly, but operating income fell due to higher expenses. The company declared a dividend of $0.24 per share, up from $0.20 YoY. Revenue growth was offset by lower profitability, with investors advised to monitor cash flow and equity earnings.